News - Corcept Therapeutics


Current filters:

Corcept Therapeutics

Popular Filters

Cushing’s syndrome patients to receive safer drug options


New upcoming treatments for Cushing’s syndrome promise to improve patient’s quality of life,…

Corcept TherapeuticsHRA PharmaKorlymMergers & AcquisitionsMifedrenNovartisPharmaceuticalRare diseasesResearchSignifor

FDA approves first Cushing’s syndrome drug, Corcept’s Korlym


Shares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.90 in after-hours trading on…

Corcept TherapeuticsKorlymNorth AmericaNovartisPharmaceuticalRare diseasesRegulationSignifor

Regulatory updates for Incivek, Xgeva and Corlux in North America


In a batch of regulatory news released yesterday, Vertex Pharmaceuticals (Nasdaq: VRTX) said that Health…

AmgenAnti-viralsCorcept TherapeuticsCorluxIncivekNorth AmericaPharmaceuticalRare diseasesRegulationVertexXgeva

Back to top